nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Carbamazepine—epilepsy syndrome	0.0391	0.0693	CbGbCtD
Imiquimod—CYP1A2—Primidone—epilepsy syndrome	0.0365	0.0647	CbGbCtD
Imiquimod—CYP1A2—Propofol—epilepsy syndrome	0.0327	0.058	CbGbCtD
Imiquimod—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0326	0.0579	CbGbCtD
Imiquimod—CYP1A2—Phenobarbital—epilepsy syndrome	0.0313	0.0554	CbGbCtD
Imiquimod—CYP3A4—Trimethadione—epilepsy syndrome	0.0303	0.0538	CbGbCtD
Imiquimod—CYP3A4—Felbamate—epilepsy syndrome	0.0303	0.0538	CbGbCtD
Imiquimod—CYP1A2—Diazepam—epilepsy syndrome	0.0296	0.0526	CbGbCtD
Imiquimod—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0285	0.0506	CbGbCtD
Imiquimod—CYP3A4—Clonazepam—epilepsy syndrome	0.0258	0.0457	CbGbCtD
Imiquimod—CYP3A4—Clobazam—epilepsy syndrome	0.0247	0.0438	CbGbCtD
Imiquimod—CYP1A2—Valproic Acid—epilepsy syndrome	0.0234	0.0414	CbGbCtD
Imiquimod—CYP3A4—Rufinamide—epilepsy syndrome	0.021	0.0373	CbGbCtD
Imiquimod—CYP3A4—Carbamazepine—epilepsy syndrome	0.0205	0.0363	CbGbCtD
Imiquimod—CYP3A4—Primidone—epilepsy syndrome	0.0191	0.0339	CbGbCtD
Imiquimod—CYP3A4—Phenytoin—epilepsy syndrome	0.0184	0.0326	CbGbCtD
Imiquimod—CYP3A4—Propofol—epilepsy syndrome	0.0171	0.0304	CbGbCtD
Imiquimod—CYP3A4—Phenobarbital—epilepsy syndrome	0.0164	0.029	CbGbCtD
Imiquimod—CYP3A4—Acetazolamide—epilepsy syndrome	0.0164	0.029	CbGbCtD
Imiquimod—CYP3A4—Midazolam—epilepsy syndrome	0.0162	0.0286	CbGbCtD
Imiquimod—CYP3A4—Diazepam—epilepsy syndrome	0.0155	0.0275	CbGbCtD
Imiquimod—CYP3A4—Zonisamide—epilepsy syndrome	0.0152	0.0269	CbGbCtD
Imiquimod—CYP3A4—Valproic Acid—epilepsy syndrome	0.0122	0.0217	CbGbCtD
Imiquimod—CYP3A4—Topiramate—epilepsy syndrome	0.011	0.0196	CbGbCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—epilepsy syndrome	0.000118	0.00108	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.000117	0.00107	CbGpPWpGaD
Imiquimod—TLR8—Immune System—S100B—epilepsy syndrome	0.000114	0.00104	CbGpPWpGaD
Imiquimod—TLR8—Immune System—SOCS3—epilepsy syndrome	0.000113	0.00103	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CDC42—epilepsy syndrome	0.000113	0.00103	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CRP—epilepsy syndrome	0.000112	0.00103	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TSC2—epilepsy syndrome	0.000112	0.00103	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTK2B—epilepsy syndrome	0.000112	0.00103	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CASP1—epilepsy syndrome	0.000112	0.00103	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—FGF2—epilepsy syndrome	0.00011	0.00101	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CCR2—epilepsy syndrome	0.000109	0.000997	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1RN—epilepsy syndrome	0.000109	0.000993	CbGpPWpGaD
Imiquimod—TLR7—Immune System—DUSP6—epilepsy syndrome	0.000108	0.000989	CbGpPWpGaD
Imiquimod—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	0.000108	0.000988	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—CAT—epilepsy syndrome	0.000108	0.000984	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.000107	0.00098	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.000107	0.000974	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—BCL2—epilepsy syndrome	0.000105	0.000955	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6ST—epilepsy syndrome	0.000103	0.000943	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL18—epilepsy syndrome	0.000103	0.000941	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	0.000103	0.000941	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	0.000103	0.000939	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	0.000102	0.000935	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—RELA—epilepsy syndrome	0.000102	0.000934	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000102	0.000933	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000101	0.000927	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD40—epilepsy syndrome	0.000101	0.000927	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000101	0.000921	CbGpPWpGaD
Imiquimod—TLR8—Immune System—FYN—epilepsy syndrome	0.0001	0.000917	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—MTOR—epilepsy syndrome	0.0001	0.000916	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.0001	0.000915	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MEF2C—epilepsy syndrome	9.98e-05	0.000912	CbGpPWpGaD
Imiquimod—TLR8—Immune System—YWHAZ—epilepsy syndrome	9.65e-05	0.000882	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	9.62e-05	0.000879	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HBEGF—epilepsy syndrome	9.54e-05	0.000872	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—FOS—epilepsy syndrome	9.45e-05	0.000864	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT3—epilepsy syndrome	9.36e-05	0.000856	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CASP8—epilepsy syndrome	9.23e-05	0.000844	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	9.16e-05	0.000837	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	9.11e-05	0.000833	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	9.04e-05	0.000826	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—JUN—epilepsy syndrome	8.96e-05	0.000818	CbGpPWpGaD
Imiquimod—TLR7—Immune System—S100B—epilepsy syndrome	8.65e-05	0.00079	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TSC2—epilepsy syndrome	8.63e-05	0.000788	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CRP—epilepsy syndrome	8.63e-05	0.000788	CbGpPWpGaD
Imiquimod—TLR7—Immune System—SOCS3—epilepsy syndrome	8.56e-05	0.000783	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CDC42—epilepsy syndrome	8.54e-05	0.000781	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—FGF2—epilepsy syndrome	8.35e-05	0.000763	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	8.31e-05	0.00076	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	8.28e-05	0.000756	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	8.23e-05	0.000752	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—SRC—epilepsy syndrome	8.03e-05	0.000734	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PRKCB—epilepsy syndrome	7.96e-05	0.000728	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6ST—epilepsy syndrome	7.93e-05	0.000725	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—BCL2—epilepsy syndrome	7.92e-05	0.000724	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL18—epilepsy syndrome	7.81e-05	0.000713	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—RELA—epilepsy syndrome	7.75e-05	0.000708	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FYN—epilepsy syndrome	7.61e-05	0.000695	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MTOR—epilepsy syndrome	7.6e-05	0.000694	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.57e-05	0.000232	CcSEcCtD
Imiquimod—Cough—Pregabalin—epilepsy syndrome	7.57e-05	0.000232	CcSEcCtD
Imiquimod—TLR7—Immune System—MEF2C—epilepsy syndrome	7.57e-05	0.000691	CbGpPWpGaD
Imiquimod—Pruritus—Phenytoin—epilepsy syndrome	7.56e-05	0.000232	CcSEcCtD
Imiquimod—Connective tissue disorder—Topiramate—epilepsy syndrome	7.55e-05	0.000231	CcSEcCtD
Imiquimod—Nausea—Levetiracetam—epilepsy syndrome	7.55e-05	0.000231	CcSEcCtD
Imiquimod—Rash—Vigabatrin—epilepsy syndrome	7.54e-05	0.000231	CcSEcCtD
Imiquimod—Dizziness—Felbamate—epilepsy syndrome	7.54e-05	0.000231	CcSEcCtD
Imiquimod—Dermatitis—Vigabatrin—epilepsy syndrome	7.53e-05	0.000231	CcSEcCtD
Imiquimod—Urethral disorder—Topiramate—epilepsy syndrome	7.53e-05	0.000231	CcSEcCtD
Imiquimod—Pruritus—Oxcarbazepine—epilepsy syndrome	7.52e-05	0.00023	CcSEcCtD
Imiquimod—Convulsion—Pregabalin—epilepsy syndrome	7.51e-05	0.00023	CcSEcCtD
Imiquimod—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.51e-05	0.00023	CcSEcCtD
Imiquimod—Headache—Vigabatrin—epilepsy syndrome	7.49e-05	0.00023	CcSEcCtD
Imiquimod—Hypertension—Pregabalin—epilepsy syndrome	7.49e-05	0.000229	CcSEcCtD
Imiquimod—Vomiting—Diazepam—epilepsy syndrome	7.49e-05	0.000229	CcSEcCtD
Imiquimod—Anorexia—Valproic Acid—epilepsy syndrome	7.46e-05	0.000229	CcSEcCtD
Imiquimod—Rash—Diazepam—epilepsy syndrome	7.43e-05	0.000227	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	7.42e-05	0.000678	CbGpPWpGaD
Imiquimod—Dermatitis—Diazepam—epilepsy syndrome	7.42e-05	0.000227	CcSEcCtD
Imiquimod—Visual impairment—Topiramate—epilepsy syndrome	7.41e-05	0.000227	CcSEcCtD
Imiquimod—Arthralgia—Pregabalin—epilepsy syndrome	7.38e-05	0.000226	CcSEcCtD
Imiquimod—Myalgia—Pregabalin—epilepsy syndrome	7.38e-05	0.000226	CcSEcCtD
Imiquimod—Chest pain—Pregabalin—epilepsy syndrome	7.38e-05	0.000226	CcSEcCtD
Imiquimod—Ill-defined disorder—Gabapentin—epilepsy syndrome	7.38e-05	0.000226	CcSEcCtD
Imiquimod—Dizziness—Zonisamide—epilepsy syndrome	7.38e-05	0.000226	CcSEcCtD
Imiquimod—Headache—Diazepam—epilepsy syndrome	7.38e-05	0.000226	CcSEcCtD
Imiquimod—Anxiety—Pregabalin—epilepsy syndrome	7.36e-05	0.000225	CcSEcCtD
Imiquimod—Diarrhoea—Clonazepam—epilepsy syndrome	7.36e-05	0.000225	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.33e-05	0.000225	CcSEcCtD
Imiquimod—Asthenia—Carbamazepine—epilepsy syndrome	7.31e-05	0.000224	CcSEcCtD
Imiquimod—TLR7—Immune System—YWHAZ—epilepsy syndrome	7.31e-05	0.000668	CbGpPWpGaD
Imiquimod—Agitation—Gabapentin—epilepsy syndrome	7.31e-05	0.000224	CcSEcCtD
Imiquimod—Diarrhoea—Phenytoin—epilepsy syndrome	7.31e-05	0.000224	CcSEcCtD
Imiquimod—Discomfort—Pregabalin—epilepsy syndrome	7.3e-05	0.000224	CcSEcCtD
Imiquimod—Nausea—Fosphenytoin—epilepsy syndrome	7.29e-05	0.000223	CcSEcCtD
Imiquimod—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.27e-05	0.000223	CcSEcCtD
Imiquimod—Erythema multiforme—Topiramate—epilepsy syndrome	7.27e-05	0.000223	CcSEcCtD
Imiquimod—Angioedema—Gabapentin—epilepsy syndrome	7.27e-05	0.000223	CcSEcCtD
Imiquimod—TLR8—Immune System—FOS—epilepsy syndrome	7.27e-05	0.000664	CbGpPWpGaD
Imiquimod—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.26e-05	0.000222	CcSEcCtD
Imiquimod—Vomiting—Felbamate—epilepsy syndrome	7.25e-05	0.000222	CcSEcCtD
Imiquimod—Dry mouth—Pregabalin—epilepsy syndrome	7.22e-05	0.000221	CcSEcCtD
Imiquimod—Pruritus—Carbamazepine—epilepsy syndrome	7.21e-05	0.000221	CcSEcCtD
Imiquimod—Rash—Felbamate—epilepsy syndrome	7.19e-05	0.00022	CcSEcCtD
Imiquimod—Eye disorder—Topiramate—epilepsy syndrome	7.18e-05	0.00022	CcSEcCtD
Imiquimod—Dermatitis—Felbamate—epilepsy syndrome	7.18e-05	0.00022	CcSEcCtD
Imiquimod—Malaise—Gabapentin—epilepsy syndrome	7.17e-05	0.00022	CcSEcCtD
Imiquimod—Tinnitus—Topiramate—epilepsy syndrome	7.17e-05	0.00022	CcSEcCtD
Imiquimod—Headache—Felbamate—epilepsy syndrome	7.14e-05	0.000219	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.13e-05	0.000219	CcSEcCtD
Imiquimod—Flushing—Topiramate—epilepsy syndrome	7.13e-05	0.000219	CcSEcCtD
Imiquimod—Syncope—Gabapentin—epilepsy syndrome	7.13e-05	0.000219	CcSEcCtD
Imiquimod—Dizziness—Clonazepam—epilepsy syndrome	7.11e-05	0.000218	CcSEcCtD
Imiquimod—Nausea—Vigabatrin—epilepsy syndrome	7.1e-05	0.000218	CcSEcCtD
Imiquimod—TLR8—Immune System—CASP8—epilepsy syndrome	7.1e-05	0.000648	CbGpPWpGaD
Imiquimod—Vomiting—Zonisamide—epilepsy syndrome	7.09e-05	0.000217	CcSEcCtD
Imiquimod—Insomnia—Valproic Acid—epilepsy syndrome	7.08e-05	0.000217	CcSEcCtD
Imiquimod—Oedema—Pregabalin—epilepsy syndrome	7.08e-05	0.000217	CcSEcCtD
Imiquimod—Asthenia—Lamotrigine—epilepsy syndrome	7.07e-05	0.000217	CcSEcCtD
Imiquimod—Dizziness—Phenytoin—epilepsy syndrome	7.06e-05	0.000216	CcSEcCtD
Imiquimod—Rash—Zonisamide—epilepsy syndrome	7.03e-05	0.000216	CcSEcCtD
Imiquimod—Infection—Pregabalin—epilepsy syndrome	7.03e-05	0.000215	CcSEcCtD
Imiquimod—Paraesthesia—Valproic Acid—epilepsy syndrome	7.03e-05	0.000215	CcSEcCtD
Imiquimod—Palpitations—Gabapentin—epilepsy syndrome	7.03e-05	0.000215	CcSEcCtD
Imiquimod—Dermatitis—Zonisamide—epilepsy syndrome	7.03e-05	0.000215	CcSEcCtD
Imiquimod—Dizziness—Oxcarbazepine—epilepsy syndrome	7.03e-05	0.000215	CcSEcCtD
Imiquimod—Nausea—Diazepam—epilepsy syndrome	6.99e-05	0.000214	CcSEcCtD
Imiquimod—Loss of consciousness—Gabapentin—epilepsy syndrome	6.99e-05	0.000214	CcSEcCtD
Imiquimod—Headache—Zonisamide—epilepsy syndrome	6.99e-05	0.000214	CcSEcCtD
Imiquimod—Dyspnoea—Valproic Acid—epilepsy syndrome	6.98e-05	0.000214	CcSEcCtD
Imiquimod—Diarrhoea—Carbamazepine—epilepsy syndrome	6.98e-05	0.000214	CcSEcCtD
Imiquimod—Angiopathy—Topiramate—epilepsy syndrome	6.97e-05	0.000214	CcSEcCtD
Imiquimod—Pruritus—Lamotrigine—epilepsy syndrome	6.97e-05	0.000214	CcSEcCtD
Imiquimod—Shock—Pregabalin—epilepsy syndrome	6.96e-05	0.000213	CcSEcCtD
Imiquimod—Somnolence—Valproic Acid—epilepsy syndrome	6.96e-05	0.000213	CcSEcCtD
Imiquimod—Immune system disorder—Topiramate—epilepsy syndrome	6.94e-05	0.000213	CcSEcCtD
Imiquimod—Nervous system disorder—Pregabalin—epilepsy syndrome	6.94e-05	0.000213	CcSEcCtD
Imiquimod—Cough—Gabapentin—epilepsy syndrome	6.94e-05	0.000213	CcSEcCtD
Imiquimod—Mediastinal disorder—Topiramate—epilepsy syndrome	6.93e-05	0.000212	CcSEcCtD
Imiquimod—Tachycardia—Pregabalin—epilepsy syndrome	6.91e-05	0.000212	CcSEcCtD
Imiquimod—Chills—Topiramate—epilepsy syndrome	6.9e-05	0.000211	CcSEcCtD
Imiquimod—Dyspepsia—Valproic Acid—epilepsy syndrome	6.89e-05	0.000211	CcSEcCtD
Imiquimod—Convulsion—Gabapentin—epilepsy syndrome	6.89e-05	0.000211	CcSEcCtD
Imiquimod—Skin disorder—Pregabalin—epilepsy syndrome	6.88e-05	0.000211	CcSEcCtD
Imiquimod—Hypertension—Gabapentin—epilepsy syndrome	6.87e-05	0.00021	CcSEcCtD
Imiquimod—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.84e-05	0.00021	CcSEcCtD
Imiquimod—Vomiting—Clonazepam—epilepsy syndrome	6.84e-05	0.000209	CcSEcCtD
Imiquimod—Decreased appetite—Valproic Acid—epilepsy syndrome	6.81e-05	0.000209	CcSEcCtD
Imiquimod—Alopecia—Topiramate—epilepsy syndrome	6.79e-05	0.000208	CcSEcCtD
Imiquimod—Vomiting—Phenytoin—epilepsy syndrome	6.79e-05	0.000208	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—JUN—epilepsy syndrome	6.79e-05	0.00062	CbGpPWpGaD
Imiquimod—Rash—Clonazepam—epilepsy syndrome	6.78e-05	0.000208	CcSEcCtD
Imiquimod—Dermatitis—Clonazepam—epilepsy syndrome	6.77e-05	0.000208	CcSEcCtD
Imiquimod—Myalgia—Gabapentin—epilepsy syndrome	6.77e-05	0.000207	CcSEcCtD
Imiquimod—Chest pain—Gabapentin—epilepsy syndrome	6.77e-05	0.000207	CcSEcCtD
Imiquimod—Arthralgia—Gabapentin—epilepsy syndrome	6.77e-05	0.000207	CcSEcCtD
Imiquimod—Nausea—Felbamate—epilepsy syndrome	6.77e-05	0.000207	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.76e-05	0.000207	CcSEcCtD
Imiquimod—Vomiting—Oxcarbazepine—epilepsy syndrome	6.75e-05	0.000207	CcSEcCtD
Imiquimod—Fatigue—Valproic Acid—epilepsy syndrome	6.75e-05	0.000207	CcSEcCtD
Imiquimod—Anxiety—Gabapentin—epilepsy syndrome	6.75e-05	0.000207	CcSEcCtD
Imiquimod—Anorexia—Pregabalin—epilepsy syndrome	6.75e-05	0.000207	CcSEcCtD
Imiquimod—Dizziness—Carbamazepine—epilepsy syndrome	6.74e-05	0.000207	CcSEcCtD
Imiquimod—Diarrhoea—Lamotrigine—epilepsy syndrome	6.74e-05	0.000207	CcSEcCtD
Imiquimod—Headache—Clonazepam—epilepsy syndrome	6.74e-05	0.000206	CcSEcCtD
Imiquimod—Rash—Phenytoin—epilepsy syndrome	6.73e-05	0.000206	CcSEcCtD
Imiquimod—Mental disorder—Topiramate—epilepsy syndrome	6.73e-05	0.000206	CcSEcCtD
Imiquimod—Dermatitis—Phenytoin—epilepsy syndrome	6.73e-05	0.000206	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.72e-05	0.000206	CcSEcCtD
Imiquimod—Rash—Oxcarbazepine—epilepsy syndrome	6.7e-05	0.000205	CcSEcCtD
Imiquimod—Pain—Valproic Acid—epilepsy syndrome	6.7e-05	0.000205	CcSEcCtD
Imiquimod—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.69e-05	0.000205	CcSEcCtD
Imiquimod—Headache—Phenytoin—epilepsy syndrome	6.69e-05	0.000205	CcSEcCtD
Imiquimod—Malnutrition—Topiramate—epilepsy syndrome	6.69e-05	0.000205	CcSEcCtD
Imiquimod—Erythema—Topiramate—epilepsy syndrome	6.69e-05	0.000205	CcSEcCtD
Imiquimod—Discomfort—Gabapentin—epilepsy syndrome	6.69e-05	0.000205	CcSEcCtD
Imiquimod—Headache—Oxcarbazepine—epilepsy syndrome	6.66e-05	0.000204	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	6.63e-05	0.000606	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	6.63e-05	0.000606	CbGpPWpGaD
Imiquimod—Nausea—Zonisamide—epilepsy syndrome	6.63e-05	0.000203	CcSEcCtD
Imiquimod—Dry mouth—Gabapentin—epilepsy syndrome	6.62e-05	0.000203	CcSEcCtD
Imiquimod—TLR7—Immune System—TSC2—epilepsy syndrome	6.54e-05	0.000597	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CRP—epilepsy syndrome	6.54e-05	0.000597	CbGpPWpGaD
Imiquimod—Dizziness—Lamotrigine—epilepsy syndrome	6.52e-05	0.0002	CcSEcCtD
Imiquimod—Oedema—Gabapentin—epilepsy syndrome	6.49e-05	0.000199	CcSEcCtD
Imiquimod—Vomiting—Carbamazepine—epilepsy syndrome	6.48e-05	0.000199	CcSEcCtD
Imiquimod—Back pain—Topiramate—epilepsy syndrome	6.47e-05	0.000198	CcSEcCtD
Imiquimod—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.45e-05	0.000198	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	6.45e-05	0.000198	CcSEcCtD
Imiquimod—Infection—Gabapentin—epilepsy syndrome	6.45e-05	0.000198	CcSEcCtD
Imiquimod—Rash—Carbamazepine—epilepsy syndrome	6.43e-05	0.000197	CcSEcCtD
Imiquimod—Dermatitis—Carbamazepine—epilepsy syndrome	6.42e-05	0.000197	CcSEcCtD
Imiquimod—TLR8—Immune System—FGF2—epilepsy syndrome	6.41e-05	0.000586	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.4e-05	0.000196	CcSEcCtD
Imiquimod—Insomnia—Pregabalin—epilepsy syndrome	6.4e-05	0.000196	CcSEcCtD
Imiquimod—Nausea—Clonazepam—epilepsy syndrome	6.39e-05	0.000196	CcSEcCtD
Imiquimod—Headache—Carbamazepine—epilepsy syndrome	6.39e-05	0.000196	CcSEcCtD
Imiquimod—Shock—Gabapentin—epilepsy syndrome	6.39e-05	0.000196	CcSEcCtD
Imiquimod—Nervous system disorder—Gabapentin—epilepsy syndrome	6.37e-05	0.000195	CcSEcCtD
Imiquimod—Paraesthesia—Pregabalin—epilepsy syndrome	6.36e-05	0.000195	CcSEcCtD
Imiquimod—Nausea—Phenytoin—epilepsy syndrome	6.34e-05	0.000194	CcSEcCtD
Imiquimod—Tachycardia—Gabapentin—epilepsy syndrome	6.33e-05	0.000194	CcSEcCtD
Imiquimod—Dyspnoea—Pregabalin—epilepsy syndrome	6.31e-05	0.000193	CcSEcCtD
Imiquimod—Nausea—Oxcarbazepine—epilepsy syndrome	6.31e-05	0.000193	CcSEcCtD
Imiquimod—Skin disorder—Gabapentin—epilepsy syndrome	6.3e-05	0.000193	CcSEcCtD
Imiquimod—Somnolence—Pregabalin—epilepsy syndrome	6.29e-05	0.000193	CcSEcCtD
Imiquimod—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.27e-05	0.000192	CcSEcCtD
Imiquimod—Vomiting—Lamotrigine—epilepsy syndrome	6.26e-05	0.000192	CcSEcCtD
Imiquimod—Urticaria—Valproic Acid—epilepsy syndrome	6.22e-05	0.000191	CcSEcCtD
Imiquimod—Rash—Lamotrigine—epilepsy syndrome	6.21e-05	0.00019	CcSEcCtD
Imiquimod—Ill-defined disorder—Topiramate—epilepsy syndrome	6.21e-05	0.00019	CcSEcCtD
Imiquimod—Dermatitis—Lamotrigine—epilepsy syndrome	6.21e-05	0.00019	CcSEcCtD
Imiquimod—Abdominal pain—Valproic Acid—epilepsy syndrome	6.19e-05	0.00019	CcSEcCtD
Imiquimod—Body temperature increased—Valproic Acid—epilepsy syndrome	6.19e-05	0.00019	CcSEcCtD
Imiquimod—Anorexia—Gabapentin—epilepsy syndrome	6.19e-05	0.00019	CcSEcCtD
Imiquimod—Headache—Lamotrigine—epilepsy syndrome	6.17e-05	0.000189	CcSEcCtD
Imiquimod—Decreased appetite—Pregabalin—epilepsy syndrome	6.15e-05	0.000189	CcSEcCtD
Imiquimod—Agitation—Topiramate—epilepsy syndrome	6.15e-05	0.000188	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.11e-05	0.000187	CcSEcCtD
Imiquimod—Fatigue—Pregabalin—epilepsy syndrome	6.1e-05	0.000187	CcSEcCtD
Imiquimod—TLR8—Immune System—BCL2—epilepsy syndrome	6.09e-05	0.000556	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—SRC—epilepsy syndrome	6.09e-05	0.000556	CbGpPWpGaD
Imiquimod—Nausea—Carbamazepine—epilepsy syndrome	6.06e-05	0.000186	CcSEcCtD
Imiquimod—Pain—Pregabalin—epilepsy syndrome	6.05e-05	0.000185	CcSEcCtD
Imiquimod—TLR7—Immune System—PRKCB—epilepsy syndrome	6.03e-05	0.000551	CbGpPWpGaD
Imiquimod—Malaise—Topiramate—epilepsy syndrome	6.03e-05	0.000185	CcSEcCtD
Imiquimod—TLR7—Immune System—IL6ST—epilepsy syndrome	6.01e-05	0.000549	CbGpPWpGaD
Imiquimod—Syncope—Topiramate—epilepsy syndrome	6e-05	0.000184	CcSEcCtD
Imiquimod—TLR8—Immune System—RELA—epilepsy syndrome	5.95e-05	0.000544	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.91e-05	0.000181	CcSEcCtD
Imiquimod—Palpitations—Topiramate—epilepsy syndrome	5.91e-05	0.000181	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	5.9e-05	0.000539	CbGpPWpGaD
Imiquimod—Loss of consciousness—Topiramate—epilepsy syndrome	5.88e-05	0.00018	CcSEcCtD
Imiquimod—Insomnia—Gabapentin—epilepsy syndrome	5.87e-05	0.00018	CcSEcCtD
Imiquimod—Nausea—Lamotrigine—epilepsy syndrome	5.85e-05	0.000179	CcSEcCtD
Imiquimod—TLR8—Immune System—MTOR—epilepsy syndrome	5.84e-05	0.000534	CbGpPWpGaD
Imiquimod—Cough—Topiramate—epilepsy syndrome	5.84e-05	0.000179	CcSEcCtD
Imiquimod—Feeling abnormal—Pregabalin—epilepsy syndrome	5.83e-05	0.000179	CcSEcCtD
Imiquimod—Paraesthesia—Gabapentin—epilepsy syndrome	5.83e-05	0.000179	CcSEcCtD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	5.81e-05	0.000531	CbGpPWpGaD
Imiquimod—Convulsion—Topiramate—epilepsy syndrome	5.8e-05	0.000178	CcSEcCtD
Imiquimod—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.79e-05	0.000177	CcSEcCtD
Imiquimod—Dyspnoea—Gabapentin—epilepsy syndrome	5.79e-05	0.000177	CcSEcCtD
Imiquimod—Hypertension—Topiramate—epilepsy syndrome	5.78e-05	0.000177	CcSEcCtD
Imiquimod—Somnolence—Gabapentin—epilepsy syndrome	5.77e-05	0.000177	CcSEcCtD
Imiquimod—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.77e-05	0.000177	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	5.74e-05	0.000524	CbGpPWpGaD
Imiquimod—Dyspepsia—Gabapentin—epilepsy syndrome	5.71e-05	0.000175	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	5.7e-05	0.000521	CbGpPWpGaD
Imiquimod—Arthralgia—Topiramate—epilepsy syndrome	5.7e-05	0.000175	CcSEcCtD
Imiquimod—Chest pain—Topiramate—epilepsy syndrome	5.7e-05	0.000175	CcSEcCtD
Imiquimod—Myalgia—Topiramate—epilepsy syndrome	5.7e-05	0.000175	CcSEcCtD
Imiquimod—Anxiety—Topiramate—epilepsy syndrome	5.68e-05	0.000174	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	5.66e-05	0.000517	CbGpPWpGaD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.66e-05	0.000173	CcSEcCtD
Imiquimod—Decreased appetite—Gabapentin—epilepsy syndrome	5.64e-05	0.000173	CcSEcCtD
Imiquimod—Discomfort—Topiramate—epilepsy syndrome	5.63e-05	0.000172	CcSEcCtD
Imiquimod—Urticaria—Pregabalin—epilepsy syndrome	5.62e-05	0.000172	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	5.62e-05	0.000513	CbGpPWpGaD
Imiquimod—Asthenia—Valproic Acid—epilepsy syndrome	5.62e-05	0.000172	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.6e-05	0.000172	CcSEcCtD
Imiquimod—Fatigue—Gabapentin—epilepsy syndrome	5.6e-05	0.000171	CcSEcCtD
Imiquimod—Abdominal pain—Pregabalin—epilepsy syndrome	5.6e-05	0.000171	CcSEcCtD
Imiquimod—Body temperature increased—Pregabalin—epilepsy syndrome	5.6e-05	0.000171	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	5.58e-05	0.00051	CbGpPWpGaD
Imiquimod—Dry mouth—Topiramate—epilepsy syndrome	5.57e-05	0.000171	CcSEcCtD
Imiquimod—Pain—Gabapentin—epilepsy syndrome	5.55e-05	0.00017	CcSEcCtD
Imiquimod—Pruritus—Valproic Acid—epilepsy syndrome	5.54e-05	0.00017	CcSEcCtD
Imiquimod—TLR7—Immune System—FOS—epilepsy syndrome	5.51e-05	0.000503	CbGpPWpGaD
Imiquimod—Oedema—Topiramate—epilepsy syndrome	5.46e-05	0.000167	CcSEcCtD
Imiquimod—Infection—Topiramate—epilepsy syndrome	5.42e-05	0.000166	CcSEcCtD
Imiquimod—TLR8—Immune System—IL1B—epilepsy syndrome	5.38e-05	0.000492	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CASP8—epilepsy syndrome	5.38e-05	0.000491	CbGpPWpGaD
Imiquimod—Shock—Topiramate—epilepsy syndrome	5.37e-05	0.000165	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	5.37e-05	0.00049	CbGpPWpGaD
Imiquimod—Diarrhoea—Valproic Acid—epilepsy syndrome	5.36e-05	0.000164	CcSEcCtD
Imiquimod—Nervous system disorder—Topiramate—epilepsy syndrome	5.36e-05	0.000164	CcSEcCtD
Imiquimod—Feeling abnormal—Gabapentin—epilepsy syndrome	5.35e-05	0.000164	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	5.34e-05	0.000488	CbGpPWpGaD
Imiquimod—Tachycardia—Topiramate—epilepsy syndrome	5.33e-05	0.000163	CcSEcCtD
Imiquimod—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.31e-05	0.000163	CcSEcCtD
Imiquimod—Skin disorder—Topiramate—epilepsy syndrome	5.3e-05	0.000163	CcSEcCtD
Imiquimod—Hyperhidrosis—Topiramate—epilepsy syndrome	5.28e-05	0.000162	CcSEcCtD
Imiquimod—TLR8—Immune System—JUN—epilepsy syndrome	5.22e-05	0.000477	CbGpPWpGaD
Imiquimod—Hypersensitivity—Pregabalin—epilepsy syndrome	5.21e-05	0.00016	CcSEcCtD
Imiquimod—Anorexia—Topiramate—epilepsy syndrome	5.21e-05	0.000159	CcSEcCtD
Imiquimod—Dizziness—Valproic Acid—epilepsy syndrome	5.18e-05	0.000159	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	5.17e-05	0.000473	CbGpPWpGaD
Imiquimod—Urticaria—Gabapentin—epilepsy syndrome	5.16e-05	0.000158	CcSEcCtD
Imiquimod—Abdominal pain—Gabapentin—epilepsy syndrome	5.13e-05	0.000157	CcSEcCtD
Imiquimod—Body temperature increased—Gabapentin—epilepsy syndrome	5.13e-05	0.000157	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	5.11e-05	0.000467	CbGpPWpGaD
Imiquimod—Asthenia—Pregabalin—epilepsy syndrome	5.08e-05	0.000156	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	5.04e-05	0.000461	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	5.03e-05	0.000459	CbGpPWpGaD
Imiquimod—Pruritus—Pregabalin—epilepsy syndrome	5.01e-05	0.000153	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—AKT1—epilepsy syndrome	4.99e-05	0.000456	CbGpPWpGaD
Imiquimod—Vomiting—Valproic Acid—epilepsy syndrome	4.98e-05	0.000153	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.98e-05	0.000152	CcSEcCtD
Imiquimod—Insomnia—Topiramate—epilepsy syndrome	4.94e-05	0.000151	CcSEcCtD
Imiquimod—Rash—Valproic Acid—epilepsy syndrome	4.94e-05	0.000151	CcSEcCtD
Imiquimod—Dermatitis—Valproic Acid—epilepsy syndrome	4.93e-05	0.000151	CcSEcCtD
Imiquimod—Headache—Valproic Acid—epilepsy syndrome	4.9e-05	0.00015	CcSEcCtD
Imiquimod—Paraesthesia—Topiramate—epilepsy syndrome	4.9e-05	0.00015	CcSEcCtD
Imiquimod—Dyspnoea—Topiramate—epilepsy syndrome	4.87e-05	0.000149	CcSEcCtD
Imiquimod—TLR7—Immune System—FGF2—epilepsy syndrome	4.86e-05	0.000444	CbGpPWpGaD
Imiquimod—Somnolence—Topiramate—epilepsy syndrome	4.85e-05	0.000149	CcSEcCtD
Imiquimod—Diarrhoea—Pregabalin—epilepsy syndrome	4.84e-05	0.000148	CcSEcCtD
Imiquimod—Dyspepsia—Topiramate—epilepsy syndrome	4.81e-05	0.000147	CcSEcCtD
Imiquimod—Hypersensitivity—Gabapentin—epilepsy syndrome	4.78e-05	0.000147	CcSEcCtD
Imiquimod—Decreased appetite—Topiramate—epilepsy syndrome	4.75e-05	0.000145	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.71e-05	0.000144	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.71e-05	0.000431	CbGpPWpGaD
Imiquimod—Fatigue—Topiramate—epilepsy syndrome	4.71e-05	0.000144	CcSEcCtD
Imiquimod—Dizziness—Pregabalin—epilepsy syndrome	4.68e-05	0.000143	CcSEcCtD
Imiquimod—TLR8—Immune System—SRC—epilepsy syndrome	4.68e-05	0.000428	CbGpPWpGaD
Imiquimod—Pain—Topiramate—epilepsy syndrome	4.67e-05	0.000143	CcSEcCtD
Imiquimod—Asthenia—Gabapentin—epilepsy syndrome	4.66e-05	0.000143	CcSEcCtD
Imiquimod—Nausea—Valproic Acid—epilepsy syndrome	4.65e-05	0.000142	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	4.64e-05	0.000424	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	4.64e-05	0.000424	CbGpPWpGaD
Imiquimod—TLR7—Immune System—BCL2—epilepsy syndrome	4.62e-05	0.000422	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.6e-05	0.00042	CbGpPWpGaD
Imiquimod—Pruritus—Gabapentin—epilepsy syndrome	4.59e-05	0.000141	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	4.52e-05	0.000413	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RELA—epilepsy syndrome	4.51e-05	0.000412	CbGpPWpGaD
Imiquimod—Vomiting—Pregabalin—epilepsy syndrome	4.5e-05	0.000138	CcSEcCtD
Imiquimod—Feeling abnormal—Topiramate—epilepsy syndrome	4.5e-05	0.000138	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.49e-05	0.00041	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.47e-05	0.000137	CcSEcCtD
Imiquimod—Rash—Pregabalin—epilepsy syndrome	4.46e-05	0.000137	CcSEcCtD
Imiquimod—Dermatitis—Pregabalin—epilepsy syndrome	4.46e-05	0.000137	CcSEcCtD
Imiquimod—Diarrhoea—Gabapentin—epilepsy syndrome	4.44e-05	0.000136	CcSEcCtD
Imiquimod—Headache—Pregabalin—epilepsy syndrome	4.43e-05	0.000136	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.43e-05	0.000404	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MTOR—epilepsy syndrome	4.43e-05	0.000404	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	4.4e-05	0.000402	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	4.37e-05	0.000399	CbGpPWpGaD
Imiquimod—Urticaria—Topiramate—epilepsy syndrome	4.34e-05	0.000133	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.34e-05	0.000396	CbGpPWpGaD
Imiquimod—Abdominal pain—Topiramate—epilepsy syndrome	4.32e-05	0.000132	CcSEcCtD
Imiquimod—Body temperature increased—Topiramate—epilepsy syndrome	4.32e-05	0.000132	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.31e-05	0.000394	CbGpPWpGaD
Imiquimod—Dizziness—Gabapentin—epilepsy syndrome	4.29e-05	0.000131	CcSEcCtD
Imiquimod—Nausea—Pregabalin—epilepsy syndrome	4.2e-05	0.000129	CcSEcCtD
Imiquimod—Vomiting—Gabapentin—epilepsy syndrome	4.13e-05	0.000126	CcSEcCtD
Imiquimod—Rash—Gabapentin—epilepsy syndrome	4.09e-05	0.000125	CcSEcCtD
Imiquimod—Dermatitis—Gabapentin—epilepsy syndrome	4.09e-05	0.000125	CcSEcCtD
Imiquimod—TLR7—Immune System—IL1B—epilepsy syndrome	4.08e-05	0.000373	CbGpPWpGaD
Imiquimod—Headache—Gabapentin—epilepsy syndrome	4.07e-05	0.000125	CcSEcCtD
Imiquimod—Hypersensitivity—Topiramate—epilepsy syndrome	4.02e-05	0.000123	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	4.02e-05	0.000367	CbGpPWpGaD
Imiquimod—TLR7—Immune System—JUN—epilepsy syndrome	3.95e-05	0.000361	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	3.94e-05	0.00036	CbGpPWpGaD
Imiquimod—Asthenia—Topiramate—epilepsy syndrome	3.92e-05	0.00012	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—CA13—epilepsy syndrome	3.9e-05	0.000356	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.89e-05	0.000355	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	3.87e-05	0.000354	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	3.87e-05	0.000354	CbGpPWpGaD
Imiquimod—Pruritus—Topiramate—epilepsy syndrome	3.86e-05	0.000118	CcSEcCtD
Imiquimod—Nausea—Gabapentin—epilepsy syndrome	3.86e-05	0.000118	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—AKT1—epilepsy syndrome	3.78e-05	0.000346	CbGpPWpGaD
Imiquimod—Diarrhoea—Topiramate—epilepsy syndrome	3.74e-05	0.000114	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.64e-05	0.000332	CbGpPWpGaD
Imiquimod—Dizziness—Topiramate—epilepsy syndrome	3.61e-05	0.000111	CcSEcCtD
Imiquimod—TLR7—Immune System—SRC—epilepsy syndrome	3.55e-05	0.000324	CbGpPWpGaD
Imiquimod—Vomiting—Topiramate—epilepsy syndrome	3.47e-05	0.000106	CcSEcCtD
Imiquimod—Rash—Topiramate—epilepsy syndrome	3.44e-05	0.000105	CcSEcCtD
Imiquimod—Dermatitis—Topiramate—epilepsy syndrome	3.44e-05	0.000105	CcSEcCtD
Imiquimod—Headache—Topiramate—epilepsy syndrome	3.42e-05	0.000105	CcSEcCtD
Imiquimod—Nausea—Topiramate—epilepsy syndrome	3.24e-05	9.94e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.14e-05	0.000287	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA13—epilepsy syndrome	3.01e-05	0.000275	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	2.95e-05	0.00027	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FAR1—epilepsy syndrome	2.95e-05	0.00027	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADK—epilepsy syndrome	2.95e-05	0.00027	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PDXK—epilepsy syndrome	2.95e-05	0.00027	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CERS1—epilepsy syndrome	2.95e-05	0.00027	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	2.95e-05	0.00027	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AKT1—epilepsy syndrome	2.91e-05	0.000266	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PNPO—epilepsy syndrome	2.7e-05	0.000247	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	2.7e-05	0.000247	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GAMT—epilepsy syndrome	2.7e-05	0.000247	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	2.7e-05	0.000247	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—QDPR—epilepsy syndrome	2.51e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CA4—epilepsy syndrome	2.51e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	2.5e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—COX3—epilepsy syndrome	2.36e-05	0.000216	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.28e-05	0.000208	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.28e-05	0.000208	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.28e-05	0.000208	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.28e-05	0.000208	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.28e-05	0.000208	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.28e-05	0.000208	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	2.24e-05	0.000205	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	2.24e-05	0.000205	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PFKL—epilepsy syndrome	2.24e-05	0.000205	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	2.24e-05	0.000205	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	2.24e-05	0.000205	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—epilepsy syndrome	2.2e-05	0.000201	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.19e-05	0.0002	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.17e-05	0.000199	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	2.08e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.08e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PNPO—epilepsy syndrome	2.08e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	2.08e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UPB1—epilepsy syndrome	2.05e-05	0.000187	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NEU1—epilepsy syndrome	2.05e-05	0.000187	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ATIC—epilepsy syndrome	2.05e-05	0.000187	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.97e-05	0.00018	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.94e-05	0.000177	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.94e-05	0.000177	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.93e-05	0.000177	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.9e-05	0.000174	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.9e-05	0.000174	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.86e-05	0.00017	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.82e-05	0.000167	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.79e-05	0.000164	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.74e-05	0.000159	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.73e-05	0.000158	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.73e-05	0.000158	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.73e-05	0.000158	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.73e-05	0.000158	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.73e-05	0.000158	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.7e-05	0.000155	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.7e-05	0.000155	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	1.62e-05	0.000148	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	1.62e-05	0.000148	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	1.58e-05	0.000145	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.58e-05	0.000144	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.58e-05	0.000144	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.58e-05	0.000144	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.55e-05	0.000142	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.52e-05	0.000139	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.52e-05	0.000139	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.49e-05	0.000136	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.47e-05	0.000134	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.47e-05	0.000134	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.4e-05	0.000128	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.38e-05	0.000126	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.36e-05	0.000124	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.34e-05	0.000123	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.31e-05	0.00012	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.31e-05	0.00012	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.3e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.25e-05	0.000114	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.25e-05	0.000114	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.23e-05	0.000112	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.23e-05	0.000112	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.22e-05	0.000112	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.2e-05	0.000109	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.17e-05	0.000107	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.15e-05	0.000105	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.14e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.12e-05	0.000102	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.08e-05	9.85e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.05e-05	9.56e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1e-05	9.14e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	9.74e-06	8.9e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	9.68e-06	8.85e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.61e-06	8.78e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	9.47e-06	8.65e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	9.47e-06	8.65e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.77e-06	8.01e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	8.74e-06	7.99e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	8.32e-06	7.6e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—BCHE—epilepsy syndrome	8.28e-06	7.57e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	7.9e-06	7.22e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	7.82e-06	7.14e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TH—epilepsy syndrome	7.79e-06	7.12e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.72e-06	7.05e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.67e-06	7.01e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.52e-06	6.87e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.47e-06	6.83e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.74e-06	6.16e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	6.5e-06	5.94e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.42e-06	5.87e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CAT—epilepsy syndrome	6.41e-06	5.86e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.39e-06	5.84e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	6.24e-06	5.7e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.1e-06	5.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.03e-06	5.51e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TH—epilepsy syndrome	6.01e-06	5.49e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPX1—epilepsy syndrome	5.8e-06	5.3e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AGT—epilepsy syndrome	5.09e-06	4.65e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.02e-06	4.58e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.98e-06	4.55e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.95e-06	4.52e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.82e-06	4.4e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.48e-06	4.09e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—POMC—epilepsy syndrome	4.28e-06	3.91e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.93e-06	3.59e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.9e-06	3.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.85e-06	3.51e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.42e-06	3.12e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.3e-06	3.02e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.01e-06	2.75e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.64e-06	2.41e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.72e-06	1.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.32e-06	1.21e-05	CbGpPWpGaD
